| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA650515 | F | In vitro reduction of p24 by 90% in Efavirenz resistant HIV-1 (K103R, V179D, P225H) infected C8166 cells. | Human immunodeficiency virus 1 | 18 | ALA1148441 | organism-based format | Scientific Literature | |
| 2. | ALA650516 | F | In vitro concentration required to reduce the amount of p24 by 90% in WTIIIB infected C8166 cells | Homo sapiens | 15 | ALA1148441 | cell-based format | Scientific Literature | |
| 3. | ALA650534 | F | Anti-HIV activity to protect MT-4 cells from HIV-1 induced cytopathogenicity by MTT method Y181C | Homo sapiens | 1 | ALA1145983 | cell-based format | Scientific Literature | |
| 4. | ALA654333 | F | Anti-HIV activity to reduce the amount of p24 in C8166 cells infected with efavirenz resistance strain HIV-1 K103R- V179D-P225H. | Homo sapiens | 3 | ALA1145983 | cell-based format | Scientific Literature | |
| 5. | ALA654335 | F | Anti-HIV activity to reduce the amount of p24 in C8166 cells infected with efavirenz resistance strain carrying mutations HIV-1 K103N-Y181C | Homo sapiens | 3 | ALA1145983 | cell-based format | Scientific Literature | |
| 6. | ALA654338 | F | Anti-HIV activity to reduce the amount of p24 in WT IIIB infected C8166 cells | Homo sapiens | 6 | ALA1145983 | cell-based format | Scientific Literature | |
| 7. | ALA683628 | B | Activity to inhibit mutant HIV-1 rRT activity in Y181C | 3 | ALA1145983 | single protein format | Scientific Literature | ||
| 8. | ALA712163 | F | In vitro cytotoxicity against mock infected MT-4 cells. | Homo sapiens | 18 | ALA1148441 | cell-based format | Scientific Literature | |
| 9. | ALA712000 | F | Inhibition of Efavirenz resistant HIV-1 (K103N-Y181C) induced cytopathicity in MT-4 cells. | Human immunodeficiency virus 1 | 18 | ALA1148441 | organism-based format | Scientific Literature | |
| 10. | ALA709794 | F | Inhibition of Efavirenz resistant HIV-1 (Y181C) induced cytopathicity in MT-4 cells. | Human immunodeficiency virus 1 | 18 | ALA1148441 | organism-based format | Scientific Literature | |
| 11. | ALA709795 | F | Inhibition of HIV-1 (IIIB) induced cytopathicity in MT-4 cells. | Human immunodeficiency virus 1 | 18 | ALA1148441 | organism-based format | Scientific Literature | |
| 12. | ALA715180 | F | Cytotoxicity, reducing the vaiability of mock-infected cells | Homo sapiens | 70 | ALA1145983 | cell-based format | Scientific Literature | |
| 13. | ALA715738 | F | Anti-HIV activity protecting MT-4 cells from HIV-1 induced cytopathogenicity | Human immunodeficiency virus 1 | 70 | ALA1145983 | organism-based format | Scientific Literature | |
| 14. | ALA799814 | B | Activity to inhibit HIV-1 Reverse transcriptase activity in K103N | 3 | ALA1145983 | single protein format | Scientific Literature | ||
| 15. | ALA799815 | B | Activity to inhibit HIV-1 Reverse transcriptase activity in WT IIIB | 3 | ALA1145983 | single protein format | Scientific Literature | ||
| 16. | ALA852314 | F | Selectivity index (Ratio of CC50/EC50). | 18 | ALA1148441 | assay format | Scientific Literature | ||
| 17. | ALA851660 | F | Selectivity ratio of CC50/EC50 | Human immunodeficiency virus 1 | 48 | ALA1145983 | organism-based format | Scientific Literature | |
| 18. | ALA833580 | F | Protection of infected MT-4 cells from wtIIIB-HIV-1-induced cytopathogenicity | 74 | ALA1145287 | cell-based format | Scientific Literature | ||
| 19. | ALA863014 | F | Antiviral activity against HIV1 | Human immunodeficiency virus 1 | 100 | ALA1147813 | organism-based format | Scientific Literature | |
| 20. | ALA953477 | F | Antiviral activity against RSV Long in human HeLa cells assessed as protection against virus-induced cytopathicity | Respiratory syncytial virus | 29 | ALA1153955 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!